Cancer Tissue Diagnostics Market Size, Situation, and Business Outlook 2022-2029

1. Paced Adoption of Cell and Gene Therapies for Personalised Treatment to Bolster Global Cancer Tissue Diagnostics Market Expansion The growing incidence of cancer has triggered a need for timely diagnosis and treatment of the disease. To accomplish this, healthcare experts are leveraging technological advancements such as automation and innovative diagnostics therapies for the timely delivery of the treatment of various types of cancers. Moreover, cell and gene therapies for personalised treatment have unlocked new avenues and innovative approaches for cancer treatment. In addition, factors such as increased health awareness, rise in screening programs, favourable government policies, and soaring healthcare expenditure are further propelling the global cancer tissue diagnostics market growth. Additionally, collaborations between cancer tissue diagnostics market players and companion diagnostics vendors will play a critical role in sustaining market growth at a considerable pace in the coming years. Get Sample Copy ofCancer Tissue Diagnostics Market: https://www.fairfieldmarketresearch.com/report/cancer-tissue-diagnostics- market/request-sample Adoption of Precision Medicine to Multiply Growth Prospects of Cancer Tissue Diagnostics Market Precision medicine is an innovative medical model that involves offering customised care to patients. In cancer, precision medicine refers to adopting tailor-made approaches in genetic screening and analysis conducted through tissue diagnostics. It helps healthcare providers in comprehending the genetic makeup and genetic profile of the affected tissues or tumours. After this, tailor-made medicines are prescribed based on the genetic tendency that caused a certain type of cancer. Moreover, pathologists also use various tissue diagnostics methods such as molecular oncology, chromosome analysis, immunohistochemistry, and mutational studies of DNA and RNA. This helps them to differentiate between the stages and types of cancers. Such unprecedented shifts in diagnostics techniques are projected to drive the cancer tissue diagnostics market to maturity. Automation and Digitalization to Facilitate Market Expansion The advancement of analytical and pre-analytical staining through the adoption of staining equipment and related-digital platforms has positively disrupted the global cancer tissue diagnostics market. In addition, the lack of skilled professionals and the growing pressure to provide timely reports have accelerated the transition to digital pathology. Digitization has enabled care providers to view the whole slide images, digital duplication of biopsy tissue using high-resolution scanners and using of high-resolution display screens. Furthermore, high- throughput pathological scanners provide high-quality images that help pathologists in the detection of malignant changes. The use of artificial intelligence in data storage, archiving, and

2. retrieving pathological images for future reference is likely to bode well for the market. Such a business landscape is poised to create sound growth opportunities for the cancer tissue diagnostics market. North America to Sustain a Strong Foothold Owing to Focused Government Initiatives North America is expected to dominate the cancer tissue diagnostics market in the foreseeable future. One key contributor to such a market positioning is a high concentration of major market players in economies such as the U.S. The country also has a well-established healthcare infrastructure, advanced cancer research centres, and favourable reimbursement policies for diagnostic tests. Additionally, increasing awareness regarding cancer has spurred demand for pathological tests in the country. Meanwhile, Asia Pacific is expected to witness the highest market growth owing to growing investments in healthcare infrastructure and high cancer incidence. Prominent Market Players Some of the most competitive players in the global cancer tissue diagnostics market include Biogenex, Bio-Rad, BioMerieux, Hologic, Jinhua Yidi Medical Appliance Co. Ltd, Thermo Fisher Scientific, Roche, Danaher, Abbott, Agilent Technologies, Sakura Fientek, Medite, Cellpath Ltd, and Dipath S.P.A. For More Information ofCancer Tissue Diagnostics Market: https://www.fairfieldmarketresearch.com/report/cancer-tissue-diagnostics-market About Us Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness. Contact Fairfield Market Research London, UK UK +44 (0)20 30025888 USA (Toll-free) +1 (844) 3829746 Web: https://www.fairfieldmarketresearch.com/ Email: sales@fairfieldmarketresearch.com Follow Us: LinkedIn